Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-25 @ 2:51 AM
NCT ID: NCT05521633
Eligibility Criteria: Inclusion Criteria: 1. Gender: Both male and female 2. Age: 18-80 Years 3. Ultrasound evidence of fatty liver as per operational definition 4. Liver enzymes as per operational definition Exclusion Criteria: 1. Pregnancy 2. Cirrhotic patients as per operational definition 3. Chronic Hepatitis B or chronic hepatitis C 4. Patients taking long term steroids, highly active antiretroviral therapy, diltiazem, irinotecan, oxaliplatin and amiodarone 5. Patients taking alcohol (based on history and AST to ALT ratio) 6. Patients with heart failure (NYHA Classification class III or IV status: patients comfortable at rest but less than ordinary physical activity causes undue fatigue, dyspnea or palpitations) 7. Patients with renal failure (serum creatinine ≥ 1.4 mg% or eGFR \< 45 ml/min/1.73 m2)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT05521633
Study Brief:
Protocol Section: NCT05521633